Funded Tech Companies
Agomab
Wondering who provided funding to Agomab? Fidelity Management & Research Company, Canaan Partners and private investors put venture money into this innovative biopharmaceutical company.
Company Overview
Company Name
Agomab
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Franklin Rooseveltlaan 348
Ghent, 9000
Belgium
Ghent, 9000
Belgium
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/11/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tim Knotnerus
Chief Financial Officer
Tolga Hassan
Chief Medical Officer
Philippe Wiesel
Chief Scientific Officer
Paolo Michieli
VP - Bus. Development
Torsten Dreier
VP - Bus. Development
Paul van der Horst
VP - General Counsel
Ellen Lefever
VP - R & D
Ramon Bosser
VP - R & D
Reginald Brys
Company Investors
- Fidelity Management & Research Company
- Canaan Partners
- EQT Life Sciences
- Dawn Biopharma
- Pfizer Venture Investments (Michael Vincent)
- Asabys Partners
- Walleye Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs